Reactivation of human herpesvirus-6 in natalizumab treated multiple sclerosis patients.

PLoS One · 2008 · PMC2323568 · PMID 18446218

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

As we have shown that CSF HHV-6 IgG was elevated in non-natalizumab treated MS groups compared to CSF from patients with OND ( Figure 3B ), there was still a trend towards higher levels of CSF HHV-6 IgG in a subset of natalizumab treated MS patients ( Figure 3B ) although this did not reach statistical significance in this limited cohort.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.